X. Chen

Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial

Chengzhi Zhao, Jingjing Miao, Gaojie Shen et al. · Annals of Oncology · 2019 · 52 citations · Full text

Anti-Sports Anaemia Effects of Verbascoside and Martynoside in Mice

Mengying Zhu, Ning‐Hua Tan, Hongli Zhu et al. · International Journal of Sports Medicine · 2010 · 18 citations

Forty Mice, Lipid Peroxidation, Verbascoside 10 +18

121O RATIONALE 309: A randomized, global, double-blind, phase III trial of tislelizumab (TIS) vs placebo, plus gemcitabine + cisplatin (GP), as first-line treatment for recurrent/metastatic nasopharyngeal cancer (RM-NPC)

Yunpeng Yang, Jingxue Pan, Hao Wang et al. · Annals of Oncology · 2021 · 14 citations

Medicine, Metronomic Therapy, Rationale 309 +10